Contribution: Industrial Research Assistance Program – Contributions to Firms
PulseMedica Corp.
$355,200.00
Prototype development for vitreous floater detection, tracking and laser treatment
FY 2022-23 · 2022-06-01
Summary
The detection, tracking and treatment of vitreous floaters in human eye is currently not possible with conventional imaging and laser technology. The proposed project involves design and development of medical device prototype that is intended to be dedicated solely for the accurate detection and treatment of vitreous floaters.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
776889289
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-06-01 | 2022-23 | $255,200.00 |
| 1 | 2022-06-01 | 2022-23 | $355,200.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 100,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 100 000 dollars.
Agreement End Date
2023-12-31
Agreement Number
991645
Agreement Start Date
2022-06-01
Agreement Title
Prototype development for vitreous floater detection, tracking and laser treatment
Agreement Title (French)
Mise au point d'un prototype pour la détection, le suivi et le traitement au laser des corps flottants du vitré
Agreement Type
Contribution
Agreement Value
$355,200.00
Amendment Date
2023-03-09
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The detection, tracking and treatment of vitreous floaters in human eye is currently not possible with conventional imaging and laser technology. The proposed project involves design and development of medical device prototype that is intended to be dedicated solely for the accurate detection and treatment of vitreous floaters.
Description (French)
La détection, le suivi et le traitement des corps flottants du vitré dans l'œil humain ne sont actuellement pas possibles avec les technologies d'imagerie et de laser conventionnelles. Le projet proposé implique la conception et la mise au point d'un prototype de dispositif médical destiné à être dédié uniquement à la détection et au traitement précis des corps flottants du vitré.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Riverbend
Federal Riding (French)
Edmonton Riverbend
Federal Riding Number
48018
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
776889289
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
PulseMedica Corp.
Recipient Postal Code
T6J 2V2
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2022-2023-Q1-991645
